CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
84 hedge funds and large institutions have $230M invested in CureVac in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 26 reducing their positions, and 14 closing their positions.
458% more call options, than puts
Call options by funds: $5.87M | Put options by funds: $1.05M
23% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 26
0.91% less ownership
Funds ownership: 15.97% → 15.06% (-0.91%)
3% less funds holding
Funds holding: 87 → 84 (-3)
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
38% less capital invested
Capital invested by funds: $373M → $230M (-$142M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$6.36M |
| 2 |
Walleye Capital
New York
|
+$3.5M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.94M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$2.54M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$2.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$14.5M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$10.5M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.86M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.32M |
| 5 |
Morgan Stanley
New York
|
-$3M |
CVAC Hedge Fund Activity: Q3 2023 in Review
84 institutional investors reported a position in CureVac (CVAC) for Q3 2023, worth a combined $230M — down 38% from $373M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of CVAC and 12 opened new positions — a net loss of 2 holders — while 26 trimmed existing stakes and 32 added.
The largest buyer was Citadel Advisors, adding an estimated $6.36M. The largest seller was RA Capital Management, cutting an estimated $14.5M.
- 84 institutional investors held CureVac (CVAC) as of Q3 2023, down from 87 in Q2 2023.
- Funds reported $230M of CureVac stock for Q3 2023, down 38% quarter-over-quarter.
- 12 funds opened new CureVac positions in Q3 2023 and 14 closed out, a net change of -2 holders.
- The largest CureVac buyer in Q3 2023 was Citadel Advisors, an estimated $6.36M added.
- The largest CureVac seller in Q3 2023 was RA Capital Management, an estimated $14.5M sold.
Based on aggregated 13F filings for Q3 2023.